FrancophonIA/ELRC3.0 huggingface dataset:
English: Administration of 25 mg alogliptin to patients with type 2 diabetes mellitus produced peak inhibition of DPP-4 within 1 to 2 hours and exceeded 93% both after a single 25 mg dose and after 14 days of once-daily dosing.
Danish: Administration af 25 mg alogliptin til patienter med type 2-diabetes mellitus medførte maksimal hæmning af DPP-4 efter 1-2 timer, og hæmningsgraden var på mere end 93 % både efter administrationen af en enkeltdosis på 25 mg og efter administrationen af samme dosis én gang dagligt i 14 dage.
English: Postmarketing reports of hepatic dysfunction including hepatic failure have been received.
Danish: Der er modtaget indberetninger efter markedsføring om funktionssvigt i leveren, herunder leversvigt.
English: Hypersensitivity reactions, including Stevens-Johnson syndrome, anaphylactic reactions, and angioedema are serious and are attributed to the alogliptin component of Vipdomet (see section 4.4).
Danish: Overfølsomhedsreaktioner, herunder Stevens-Johnsons syndrom, anafylaktiske reaktioner og angioødem er alvorlige bivirkninger og tilskrives alogliptin-komponenten i Vipdomet (se pkt.
English: Alogliptin has not been studied in patients with severe hepatic impairment (Child-Pugh score >9).
Danish: Alogliptin er ikke undersøgt hos patienter med svært nedsat leverfunktion (Child-Pugh-scorer > 9).
English: Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant doses (see section 5.3).
Danish: Dyreforsøg indikerer hverken direkte eller indirekte skadelige virkninger hvad angår reproduktionstoksicitet ved klinisk relevante doser (se pkt.
English: In rats no treatment-related foetal abnormalities occurred following concomitant administration at exposure margins of approximately 28- to 29-fold for alogliptin and 2- to 2.5-fold for metformin at the maximum recommended human dose of 25 mg/day and 2,000 mg/day, respectively.
Danish: I studier med rotter forekom der ingen behandlingsrelaterede føtale anormaliteter efter samtidig administration af alogliptin og metformin ved eksponeringer, der var henholdsvis 28 til 29 gange og 2 til 2,5 gange den maksimale anbefalede humane dosis på henholdsvis 25 mg om dagen og 2.000 mg om dagen.
English: - difficulty in breathing - reduced body temperature and heartbeat.
Danish: - almen utilpashed med udpræget træthed - vejrtrækningsbesvær - nedsat kropstemperatur og langsommere puls.
English: Both of these groups of medicines are “oral anti-diabetics”.
Danish: Begge disse lægemidler kaldes orale antidiabetika (diabetesmedicin, der indtages gennem munden).
English: crospovidone Type A, magnesium stearate, hypromellose, talc, titanium dioxide (E171) and yellow iron oxide (E172).
Danish: Øvrige indholdsstoffer: mannitol, mikrokrystallinsk cellulose, povidon K30, crospovidon type A, magnesiumstearat, hypromellose, talkum, titandioxid (E171) og gul jernoxid (E172).
English: A total of 7,151 patients with type 2 diabetes mellitus, including 4,202 patients treated with alogliptin and metformin, participated in 7 phase 3 double-blind, placebo- or active-controlled clinical studies conducted to evaluate the effects of co-administered alogliptin and metformin on glycaemic control and their safety.
Danish: I alt 7.151 patienter med type 2-diabetes mellitus, herunder 4.202 patienter, som blev behandlet med alogliptin og metformin, deltog i 7 dobbeltblindede kliniske fase III-studier med placebo eller aktiv kontrol, som blev gennemført for at evaluere virkningen af samtidig administration af alogliptin og metformin på den glykæmiske kontrol samt lægemidlernes sikkerhedsprofil.
English: MARKETING AUTHORISATION NUMBER(S) EU/1/13/843/001-026
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE) EU/1/13/843/001-026
English: In a pooled analysis of the data from 12 studies, the overall incidence of any episode of hypoglycaemia was similar in patients ≥65 years old treated with 25 mg alogliptin (3.8%) to that in patients <65 years old (3.6%).
Danish: En samlet analyse af data fra 12 studier viste, at den samlede forekomst af hypoglykæmi var den samme for patienter på 65 år og derover behandlet med 25 mg alogliptin (3,8 %) som for patienter under 65 år (3,6 %).
English: Maximum daily dose is 6.25 mg * Alogliptin dose adjustment is based on a pharmacokinetic study where kidney function was assessed using creatinine clearance (CrCl) levels estimated from the Cockcroft-Gault equation.
Danish: *Justeringer af alogliptindosis er baseret på et farmakokinetisk studie, hvor nyrefunktionen blev vurderet på grundlag af kreatinin-clearance-niveauer (CrCl), som blev estimeret ud fra Cockcroft-Gault-ligningen.
English: Clinically meaningful reductions in HbA1c compared to control were also observed regardless of baseline background treatment.
Danish: Klinisk relevante reduktioner i HbA1c sammenlignet med kontrol blev observeret uanset baggrundsbehandling ved baseline.
English: Alogliptin has not been studied in patients with severe hepatic impairment (Child-Pugh score >9) and is, therefore, not recommended for use in such patients (see sections 4.2, 4.3 and 5.2).
Danish: Alogliptin er ikke undersøgt hos patienter med svært nedsat leverfunktion (Child-Pugh-score > 9), og det anbefales derfor ikke til disse patienter (se pkt.
English: PHARMACEUTICAL FORM AND CONTENTS 98 film-coated tablets
Danish: LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE) 98 filmovertrukne tabletter
English: No studies in lactating animals have been conducted with the combined active substances of Vipdomet.
Danish: Der er ikke gennemført studier af administration af kombinationen af de aktive stoffer i Vipdomet til diegivende dyr.
English: What Vipdomet contains - The active substances are alogliptin and metformin hydrochloride.
Danish: Pakningsstørrelser og yderligere oplysninger Vipdomet indeholder: Aktive stoffer: alogliptin og metforminhydrochlorid.
English: The following section outlines the pharmacokinetic properties of the individual components of Vipdomet (alogliptin/metformin) as reported in their respective Summary of Product Characteristics.
Danish: I det følgende gennemgås de farmakokinetiske egenskaber ved de enkelte komponenter i Vipdomet (alogliptin og metformin), som de er beskrevet i komponenternes respektive produktresuméer.
English: The following section outlines the interactions observed with the individual components of Vipdomet (alogliptin/metformin) as reported in their respective Summary of Product Characteristics.
Danish: Nedenfor gennemgås de interaktioner, der er observeret for de enkelte komponenter i Vipdomet (alogliptin/metformin), og som er beskrevet i deres respektive produktresuméer.
English: Symptoms of a serious allergic reaction may include; rash, raised red patches on your skin (hives), swelling of the face, lips, tongue, and throat that may cause difficulty in breathing or swallowing.
Danish: Tegn på en alvorlig allergisk reaktion kan være udslæt, hævede røde områder på huden (nældefeber) og hævelse af ansigtet, læber, tunge eller svælg, som kan gøre det svært for dig at trække vejret eller synke.
English: These studies evaluated the effects of co-administered alogliptin and metformin on glycaemic control and their safety as initial combination therapy, as dual therapy in patients initially treated with metformin alone, and as add-on therapy to a thiazolidinedione or insulin.
Danish: Formålet med disse studier var at evaluere virkningen af samtidigt administreret alogliptin og metformin på den glykæmiske regulering og disse stoffers sikkerhed, når de gives som initial kombinationsbehandling, som tostofbehandling til patienter, der oprindelig er blevet behandlet med metformin alene, og som tillægsbehandling til behandling med thiazolidindion eller insulin.
English: Metabolism and nutrition disorders lactic acidosis very rare vitamin B12 deficiency very rare hypoglycaemia common common
Danish: B12-vitaminmangel meget sjælden hypoglykæmi almindelig almindelig
English: Factors that may increase the risk of lactic acidosis (see section 4.4) should be reviewed before considering initiation of metformin in patients with GFR<60 mL/min.
Danish: 4.4), skal gennemgås, inden påbegyndelse af metforminbehandling overvejes hos patienter med GFR < 60 ml/min.
English: Therefore, haemodialysis is of little clinical benefit in removing alogliptin in overdose.
Danish: Hæmodialyse gør således kun begrænset klinisk gavn ved overdosering.
English: - if you have -severely reduced kidney function - if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactate acidosis (see “Risk of lactic acidosis” below) or ketoacidosis.
Danish: • Hvis du har dårligt kontrolleret diabetes, der eksempelvis er ledsaget af alvorlig hyperglykæmi (højt blodsukker), kvalme, opkastning, diarré, hurtigt vægttab, laktatacidose (se ”Risiko for laktatacidose” nedenfor) eller ketoacidose.
English: No dose adjustment Maximum daily dose is 25 mg
Danish: Dosisjustering ikke nødvendig Maksimal daglig dosis er 25 mg
English: There are no data from the use of Vipdomet in pregnant women.
Danish: Der er ingen eller utilstrækkelige data fra anvendelse af Vipdomet til gravide kvinder.
English: Table 2: Change in HbA1c (%) from baseline with alogliptin 25 mg at Week 26 by placebo-controlled study (FAS, LOCF)
Danish: Tabel 2 Ændring i HbA1c (%) med alogliptin 25 mg fra baseline til uge 26 i studier med placebo (FAS, LOCF)
English: Co-administration of 100 mg alogliptin once daily and 1,000 mg metformin hydrochloride twice daily for 6 days in healthy subjects had no clinically relevant effects on the pharmacokinetics of alogliptin or metformin.
Danish: Samtidig administration af 100 mg alogliptin én gang dagligt og 1.000 mg metforminhydrochlorid to gange dagligt i 6 dage hos raske forsøgspersoner havde ingen klinisk relevante effekter på farmakokinetikken for alogliptin eller metformin.
English: Change at Week 104 (n=382)
Danish: Ændring i uge 104 (n = 382)
English: Placebo-corrected change from baseline in HbA1c (%)†
Danish: Placebo-korrigeret ændring fra baseline i HbA1c (%)†
English: Both 25 mg alogliptin alone and in combination with 30 mg pioglitazone demonstrated significant decreases in postprandial glucose and postprandial glucagon whilst significantly increasing postprandial active GLP-1 levels at Week 16 compared to placebo (p<0.05).
Danish: Ved administration af 25 mg alogliptin både alene og sammen med 30 mg pioglitazon var der et betydeligt fald i postprandial glucose og postprandial glukagon, mens der var en betydelig stigning i de postprandiale aktive GLP-1-niveauer i uge 16 sammenlignet med placebo (p< 0,05).
English: PHARMACEUTICAL FORM AND CONTENTS Multipack: 196 (2 packs of 98) film-coated tablets.
Danish: LÆGEMIDDELFORM OG INDHOLD (PAKNINGSSTØRRELSE) Multipakning: 196 (2 pakninger a 98) filmovertrukne tabletter.
English: If a dose is missed, it should be taken as soon as the patient remembers.
Danish: Hvis en dosis glemmes, skal den tages, så snart patienten husker det. Der må ikke tages en dobbeltdosis på én gang.
English: For patients inadequately controlled on the maximal tolerated dose of metformin hydrochloride alone, the recommended dose is one tablet of 12.5 mg/850 mg or 12.5 mg/1,000 mg twice daily, corresponding to 25 mg alogliptin plus 1,700 mg or 2,000 mg metformin hydrochloride daily, depending on the dose of metformin hydrochloride already being taken.
Danish: For patienter, som er utilstrækkeligt reguleret på den maksimalt tolererede dosis metforminhydrochlorid alene, er den anbefalede dosis én tablet på 12,5 mg/850 mg eller på 12,5 mg/1.000 mg to gange dagligt svarende til 25 mg alogliptin plus 1.700 mg eller 2.000 mg metforminhydrochlorid dagligt, afhængigt af hvilken dosis metforminhydrochlorid de allerede får.
English: The overall incidence of episodes of severe hypoglycaemia was comparable in patients treated with 25 mg alogliptin or 12.5 mg alogliptin, and lower than the incidence in patients treated with active control or placebo (0.1%, 0.1%, 0.4% and 0.4%, respectively).
Danish: Den samlede forekomst af episoder med svær hypoglykæmi var på samme niveau hos patienter behandlet med 25 mg alogliptin eller 12,5 mg alogliptin, og dette niveau var lavere end forekomsten hos patienter behandlet med aktiv kontrol eller placebo (henholdsvis 0,1 %, 0,1 %, 0,4 % og 0,4).
English: Risk related to metformin
Danish: Risikorelateret til metformin
English: In addition, 25 mg alogliptin alone and in combination with 30 mg pioglitazone produced statistically significant (p<0.001) reductions in total triglycerides at Week 16 as measured by postprandial incremental AUC(0-8) change from baseline compared to placebo.
Danish: Desuden medførte 25 mg alogliptin administreret både alene og sammen med 30 mg pioglitazon statistisk signifikante (p< 0,001) fald i totaltriglycerider fra baseline til uge 16 målt som den postprandiale gradvise ændring i AUC(0-8) sammenlignet med placebo.
English: Alogliptin 25 mg once daily with a thiazolidinedione + metformin vs a titrating thiazolidinedione + metformin
Danish: Alogliptin 25 mg én gang dagligt sammen med et thiazolidindion + metformin versus titrering af et thiazolidindion + metformin
English: Clinical studies conducted to support the efficacy and safety of Vipdomet involved the co-administration of alogliptin and metformin as separate tablets.
Danish: Kliniske studier, som blev udført for at understøtte virkningen af og sikkerheden ved Vipdomet, omfattede samtidig administration af alogliptin og metformin som separate tabletter.
English: Very rare (may affect up to 1 in 10,000 people): - Lactic acidosis (a build-up of lactic acid in the blood) is a very serious side effect that may lead to coma.
Danish: • Laktatacidose (ophobning af mælkesyre i blodet) er en meget alvorlig bivirkning, som kan føre til koma.
English: Medicinal products with intrinsic hyperglycaemic activity Glucocorticoids (given by systemic and local routes), beta-2-agonists and diuretics (see also section 4.4) have intrinsic hyperglycaemic activity.
Danish: Lægemidler med intrinsisk hyperglykæmisk aktivitet Glukokortikoider (administreret via systemiske og lokale administrationsveje), beta-2-antagonister og diuretika (se også pkt.
English: Therefore, a lower dose of insulin may be considered to reduce the risk of hypoglycaemia when this medicinal product is used in combination with Vipdomet (see section 4.2).
Danish: Derfor kan det overvejes at sænke dosis for insulin for at nedsætte risikoen for hypoglykæmi, hvis insulin anvendes i kombination med Vipdomet (se pkt.
English: No data are available (see section 4.2 and above).
Danish: 4.2 og ovenfor).
English: - in combination with insulin (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.
Danish: • i kombination med insulin (dvs. trestofbehandling) som supplement til diæt og motion med det formål at forbedre den glykæmiske kontrol hos patienter, som ikke opnår tilstrækkelig glykæmisk kontrol med insulin i stabil dosis og metformin alene.
English: The co-administration of alogliptin and metformin has been studied as dual therapy in patients initially treated with metformin alone, and as add-on therapy to a thiazolidinedione or insulin.
Danish: Samtidig indgift af alogliptin og metformin er blevet undersøgt som tostofbehandling til patienter, der oprindelig er behandlet med metformin alene, og som tillægsbehandling til thiazolidindion eller insulin.
English: (-infinity, -0.28)
Danish: (-uendelig, -0,28)
English: - in case of symptoms suggestive of liver injury during Vipdomet therapy.
Danish: • hvis du får symptomer, der tyder på en leverskade, mens du tager Vipdomet.
English: The significant reductions in HbA1c observed with 25 mg alogliptin plus 30 mg pioglitazone and metformin were consistent over the entire 52-week treatment period compared to 45 mg pioglitazone and metformin (p<0.001 at all time points).
Danish: De signifikante fald i HbA1c observeret med 25 mg alogliptin og 30 mg pioglitazon og metformin var ensartede gennem behandlingsperioden på 52 uger sammenlignet med behandling med 45 mg pioglitazon og metformin (p<0,001 til alle tidspunkter).
English: In a pooled analysis of the data from 12 studies, the overall incidence of any episode of hypoglycaemia was lower in patients treated with 25 mg alogliptin than in patients treated with 12.5 mg alogliptin, active control or placebo (3.6%, 4.6%, 12.9% and 6.2%, respectively).
Danish: En samlet analyse af data fra 12 studier viste, at den samlede forekomst af hypoglykæmi var lavere hos patienter behandlet med 25 mg alogliptin end hos patienter behandlet med 12,5 mg alogliptin, aktiv kontrol eller placebo (henholdsvis 3,6 %, 4,6 %, 12,9 % og 6,2 %).
English: The pharmacokinetics of alogliptin in children and adolescents <18 years old has not been established.
Danish: Alogliptins farmakokinetik hos børn og unge under 18 år er ikke klarlagt.
English: The safety and efficacy of Vipdomet in children and adolescents <18 years old have not been established.
Danish: Vipdomet sikkerhed og virkning hos børn og unge under 18 år er ikke klarlagt.
English: Common (may affect up to 1 in 10 people): - Symptoms of low blood sugar (hypoglycaemia) may occur when Vipdomet is taken in combination with insulin or sulphonylureas (e.g. glipizide, tolbutamide, glibenclamide).
Danish: • Tegn på lavt blodsukker (hypoglykæmi), som kan opstå, hvis Vipdomet tages i kombination med insulin eller sulfonylurinstof (f.eks. glipizid, tolbutamid eller glibenclamid).
English: Add-on combination therapy placebo-controlled studies Alogliptin 25 mg once daily with metformin (n=203)
Danish: Placebokontrolleret studie med kombinationsbehandling som supplement Alogliptin 25 mg én gang dagligt sammen med metformin (n = 203)
English: Vipdomet is not recommended during breast-feeding since metformin passes into breast milk.
Danish: Det frarådes, at du tager Vipdomet, hvis du ammer, da indholdsstoffet metformin udskilles i modermælken.
English: It should also be taken with meals to reduce the gastrointestinal undesirable effects associated with metformin (see section 4.2).
Danish: Lægemidlet skal også tages sammen med et måltid for at reducere de gastrointestinale bivirkninger ved metformin (se pkt.
English: Due to its metformin component, Vipdomet should not be used in patients with severe renal impairment, or end-stage renal disease requiring dialysis (see section 4.2).
Danish: På grund af indholdet af metformin må Vipdomet ikke anvendes til patienter med svært nedsat nyrefunktion eller terminal nyresygdom (se pkt.
English: However, the results of bioequivalence studies have demonstrated that Vipdomet film-coated tablets are bioequivalent to the corresponding doses of alogliptin and metformin co-administered as separate tablets.
Danish: Bioækvivalensstudier viser imidlertid, at Vipdomet, filmovertrukne tabletter er bioækvivalente med tilsvarende doser af alogliptin og metformin givet samtidigt som separate tabletter.
English: (-infinity, -0.35)
Danish: (-uendelig, -0,35)
English: Change at Week 52 (n=382)
Danish: Ændring i uge 52 (n = 382)
English: For patients switching from separate tablets of alogliptin and metformin (as dual therapy or as part of triple therapy with insulin), both alogliptin and metformin should be dosed at the total daily dose already being taken; the individual dose of alogliptin should be halved as it will be taken twice daily whilst the dosing of metformin should remain unchanged.
Danish: Patienter, der skifter fra separate alogliptin- og metformin-tabletter (som tostofbehandling eller som trestofbehandling sammen med insulin), skal tage den samme daglige dosis af både alogliptin og metformin.
English: INFORMATION IN BRAILLE Vipdomet 12.5 mg/850 mg
Danish: INFORMATION I BRAILLESKRIFT Vipdomet 12,5 mg/850 mg
English: - if you are taking another medicine for diabetes that contains a “sulphonylurea”, you should not start taking Vipdomet.
Danish: • hvis du tager et andet lægemiddel mod diabetes, som indeholder et såkaldt sulfonylurinstof.
English: Significantly more patients receiving 12.5 mg alogliptin and 1.000 mg metformin hydrochloride twice daily (59.5%) achieved target HbA1c levels of < 7.0% compared to those receiving either 12.5 mg alogliptin twice daily alone (20.2%, p<0.001) or 1,000 mg metformin hydrochloride twice daily alone (34.3%, p<0.001) at Week 26.
Danish: Signifikant flere af de patienter, der fik 12,5 mg alogliptin og 1.000 mg metforminhydrochlorid to gange dagligt (59,5 %), nåede i uge 26 behandlingsmålet for HbA1c på < 7,0 % sammenlignet med dem, der fik 12,5 mg alogliptin givet alene to gange dagligt (20,2 %, p<0,001), og sammenlignet med dem, der fik 1.000 mg metforminhydrochlorid givet alene to gange dagligt (34,3 %, p<0,001).
English: The pharmacokinetics of Vipdomet in children and adolescents <18 years old has not been established.
Danish: Vipdomets farmakokinetik hos børn og unge under 18 år er ikke klarlagt.
English: Liver function test abnormalities very rare hepatic dysfunction including hepatic failure not known
Danish: Lever- og galdeveje hepatitis meget sjælden uregelmæssige værdier set i leverfunktionstest meget sjælden leverdysfunktion herunder leversvigt ikke kendt
English: For patients inadequately controlled on dual therapy with a maximal tolerated dose of metformin and pioglitazone, the dose of pioglitazone should be maintained, and Vipdomet administered concomitantly; alogliptin should be dosed at 12.5 mg twice daily (25 mg total daily dose) and metformin hydrochloride at a similar dose (either 850 mg or 1,000 mg twice daily) to that already being taken.
Danish: For patienter, der ikke opnår tilstrækkelig kontrol ved tostofbehandling med de maksimalt tolererede doser metformin og pioglitazon, skal dosis for pioglitazon fastholdes og Vipdomet skal administreres samtidigt; der skal gives 12,5 mg alogliptin to gange dagligt (25 mg i alt pr. dag) og metforminhydrochlorid i en dosis, der svarer til den, de allerede får (enten 850 mg eller 1.000 mg to gange dagligt).
English: Food slightly delays and decreases the extent of the absorption of metformin.
Danish: Ved fødeindtagelse bliver metforminabsorptionen en anelse forsinket og reduceret.
English: At Week 52, the HbA1c reduction by 25 mg alogliptin plus metformin (-0.76%, Table 3) was similar to that produced by glipizide (mean dose = 5.2 mg) plus metformin hydrochloride therapy (mean dose = 1,824 mg, -0.73%).
Danish: I uge 52 svarede reduktionen i HbA1c med 25 mg alogliptin plus metformin (-0,76 %, tabel 3) til den, som blev opnået med glipizid (gennemsnitlig dosis = 5,2 mg) plus metforminhydrochloridbehandling (gennemsnitsdosis = 1.824 mg, -0,73 %).
English: No adverse effects on fertility were observed in animal studies conducted with alogliptin or with metformin (see section 5.3).
Danish: I dyrestudier gennemført med alogliptin eller med metformin er der ikke observeret nogen indvirkninger på fertilitet (se pkt.
English: Co-administration of 12.5 mg alogliptin and 1,000 mg metformin hydrochloride twice daily resulted in statistically significant improvements from baseline in HbA1c and fasting plasma glucose at Week 26 when compared to either 12.5 mg alogliptin twice daily alone or 1,000 mg metformin hydrochloride twice daily alone.
Danish: Samtidig administration af 12,5 mg alogliptin og 1.000 mg metforminhydrochlorid to gange dagligt resulterede i statistisk signifikante forbedringer af HbA1c og fasteplasmaglucose fra baseline til uge 26 sammenlignet med både 12,5 mg alogliptin givet alene to gange dagligt og 1.000 mg metforminhydrochlorid givet alene to gange dagligt.
English: Vipdomet should be discontinued prior to or at the time of the imaging procedure and not restarted until at least 48 hours after, provided that renal function has been re-evaluated and found to be stable, see sections 4.2 and 4.5.
Danish: Behandling med Vipdomet skal afbrydes forud for eller på tidspunktet for billeddiagnostiske procedurer og først genoptages mindst 48 timer herefter, forudsat at nyrefunktionen er blevet vurderet og fundet stabil, se pkt.